{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T01:34:41Z","timestamp":1789004081947,"version":"build-2803163510"},"reference-count":70,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["DP120100064"],"award-info":[{"award-number":["DP120100064"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["DP180103875"],"award-info":[{"award-number":["DP180103875"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["DP170103076"],"award-info":[{"award-number":["DP170103076"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["DE170100785"],"award-info":[{"award-number":["DE170100785"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1134989"],"award-info":[{"award-number":["1134989"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1135820"],"award-info":[{"award-number":["1135820"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1104975"],"award-info":[{"award-number":["1104975"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1143974"],"award-info":[{"award-number":["1143974"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1132975"],"award-info":[{"award-number":["1132975"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1138860"],"award-info":[{"award-number":["1138860"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1126399"],"award-info":[{"award-number":["1126399"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1141921"],"award-info":[{"award-number":["1141921"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1082022"],"award-info":[{"award-number":["1082022"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1080001"],"award-info":[{"award-number":["1080001"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1100394"],"award-info":[{"award-number":["1100394"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1028641"],"award-info":[{"award-number":["1028641"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1028643"],"award-info":[{"award-number":["1028643"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Parasitology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.pt.2020.02.005","type":"journal-article","created":{"date-parts":[[2020,3,21]],"date-time":"2020-03-21T08:23:52Z","timestamp":1584779032000},"page":"413-426","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Malaria Parasite Clearance: What Are We Really Measuring?"],"prefix":"10.1016","volume":"36","author":[{"given":"David S.","family":"Khoury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie G.","family":"Zaloumis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Grigg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraful","family":"Haque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miles P.","family":"Davenport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pt.2020.02.005_bb0005","series-title":"World malaria Report 2018","author":"World Health Organization","year":"2018"},{"key":"10.1016\/j.pt.2020.02.005_bb0010","series-title":"World Malaria Report 2016","author":"World Health Organization","year":"2016"},{"key":"10.1016\/j.pt.2020.02.005_bb0015","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(05)67176-0","article-title":"Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial","volume":"366","author":"Dondorp","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.pt.2020.02.005_bb0020","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/S0140-6736(10)61924-1","article-title":"Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial","volume":"376","author":"Dondorp","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.pt.2020.02.005_bb0025","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMoa0808859","article-title":"Artemisinin resistance in Plasmodium falciparum malaria","volume":"361","author":"Dondorp","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pt.2020.02.005_bb0030","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1016\/S0140-6736(12)60484-X","article-title":"Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study","volume":"379","author":"Phyo","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.pt.2020.02.005_bb0035","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1473-3099(15)00487-9","article-title":"Dihydroartemisinin\u2013piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study","volume":"16","author":"Amaratunga","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.pt.2020.02.005_bb0040","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1314981","article-title":"Spread of artemisinin resistance in Plasmodium falciparum malaria","volume":"371","author":"Ashley","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pt.2020.02.005_bb0045","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/1475-2875-10-278","article-title":"The parasite clearance curve","volume":"10","author":"White","year":"2011","journal-title":"Malar. J."},{"key":"10.1016\/j.pt.2020.02.005_bb0050","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12936-017-1731-1","article-title":"Malaria parasite clearance","volume":"16","author":"White","year":"2017","journal-title":"Malar. J."},{"key":"10.1016\/j.pt.2020.02.005_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021914","article-title":"A pilot randomised trial of induced blood-stage Plasmodium falciparum infections in healthy volunteers for testing efficacy of new antimalarial drugs","volume":"6","author":"McCarthy","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pt.2020.02.005_bb0060","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nrd4683","article-title":"Hit and lead criteria in drug discovery for infectious diseases of the developing world","volume":"14","author":"Katsuno","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.pt.2020.02.005_bb0065","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12936-016-1675-x","article-title":"New developments in anti-malarial target candidate and product profiles","volume":"16","author":"Burrows","year":"2017","journal-title":"Malar. J."},{"key":"10.1016\/j.pt.2020.02.005_bb0070","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S1473-3099(17)30171-8","article-title":"Safety, tolerability, pharmacokinetics, and activity of the novel long-acting antimalarial DSM265: a two-part first-in-human phase 1a\/1b randomised study","volume":"17","author":"McCarthy","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.pt.2020.02.005_bb0075","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1128\/AAC.04942-14","article-title":"Evaluating the pharmacodynamic effect of antimalarial drugs in clinical trials by quantitative PCR","volume":"59","author":"Marquart","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pt.2020.02.005_bb0080","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1186\/s12936-016-1511-3","article-title":"A Phase II pilot trial to evaluate safety and efficacy of ferroquine against early Plasmodium falciparum in an induced blood-stage malaria infection study","volume":"15","author":"McCarthy","year":"2016","journal-title":"Malar. J."},{"key":"10.1016\/j.pt.2020.02.005_bb0085","doi-asserted-by":"crossref","first-page":"E5455","DOI":"10.1073\/pnas.1414221111","article-title":"(+)-SJ733, a clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance of Plasmodium","volume":"111","author":"Jim\u00e9nez-D\u00edaz","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pt.2020.02.005_bb0090","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S1473-3099(15)00415-6","article-title":"Artesunate\u2013mefloquine versus chloroquine for treatment of uncomplicated Plasmodium knowlesi malaria in Malaysia (ACT KNOW): an open-label, randomised controlled trial","volume":"16","author":"Grigg","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.pt.2020.02.005_bb0095","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1093\/cid\/ciw121","article-title":"Efficacy of artesunate-mefloquine for chloroquine-resistant Plasmodium vivax malaria in Malaysia: an open-label, randomized, controlled trial","volume":"62","author":"Grigg","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.pt.2020.02.005_bb0100","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.pt.2016.09.004","article-title":"Mathematical modelling to guide drug development for malaria elimination","volume":"33","author":"Slater","year":"2017","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.pt.2020.02.005_bb0105","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.ijpara.2018.05.010","article-title":"Quantification of host-mediated parasite clearance during blood-stage Plasmodium infection and anti-malarial drug treatment in mice","volume":"48","author":"Aogo","year":"2018","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.pt.2020.02.005_bb0110","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.ijpara.2017.05.009","article-title":"Characterizing the effect of antimalarial drugs on the maturation and clearance of murine blood-stage Plasmodium parasites in vivo","volume":"47","author":"Khoury","year":"2017","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.pt.2020.02.005_bb0115","doi-asserted-by":"crossref","first-page":"6428","DOI":"10.1128\/AAC.00481-15","article-title":"How robust are malaria parasite clearance rates as indicators of drug effectiveness and resistance?","volume":"59","author":"Hastings","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pt.2020.02.005_bb0120","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1073\/pnas.1615875114","article-title":"Host immunity to Plasmodium falciparum and the assessment of emerging artemisinin resistance in a multinational cohort","volume":"114","author":"Ataide","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pt.2020.02.005_bb0125","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/imr.12697","article-title":"Within-host modeling of blood-stage malaria","volume":"285","author":"Khoury","year":"2018","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.pt.2020.02.005_bb0130","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1086\/315718","article-title":"The mechanisms of parasite clearance after antimalarial treatment of Plasmodium falciparum malaria","volume":"182","author":"Chotivanich","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.pt.2020.02.005_bb0135","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1073\/pnas.1006113108","article-title":"Intrahost modeling of artemisinin resistance in Plasmodium falciparum","volume":"108","author":"Saralamba","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pt.2020.02.005_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1002132","article-title":"Targeting the cell stress response of Plasmodium falciparum to overcome artemisinin resistance","volume":"13","author":"Dogovski","year":"2015","journal-title":"PLoS Biol."},{"key":"10.1016\/j.pt.2020.02.005_bb0145","doi-asserted-by":"crossref","first-page":"303","DOI":"10.4269\/ajtmh.1995.53.303","article-title":"Parasite viability during treatment of severe falciparum malaria: differential effects of artemether and quinine","volume":"53","author":"Murphy","year":"1995","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.pt.2020.02.005_bb0150","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s002280050449","article-title":"Viability of Plasmodium falciparum ex vivo: comparison of the effects of artemether and sulfadoxine-pyrimethamine","volume":"54","author":"Sowunmi","year":"1998","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.pt.2020.02.005_bb0155","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4269\/ajtmh.1993.49.106","article-title":"Falciparum malaria: differential effects of antimalarial drugs on ex vivo parasite viability during the critical early phase of therapy","volume":"49","author":"Watkins","year":"1993","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.pt.2020.02.005_bb0160","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1086\/656476","article-title":"Artemisinin-induced dormancy in plasmodium falciparum: duration, recovery rates, and implications in treatment failure","volume":"202","author":"Teuscher","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.pt.2020.02.005_bb0165","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1208\/s12248-014-9647-y","article-title":"Making the most of clinical data: reviewing the role of pharmacokinetic-pharmacodynamic models of anti-malarial drugs","volume":"16","author":"Simpson","year":"2014","journal-title":"AAPS J."},{"key":"10.1016\/j.pt.2020.02.005_bb0170","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00228-002-0485-y","article-title":"Population pharmacokinetic and pharmacodynamic modelling of artemisinin and mefloquine enantiomers in patients with falciparum malaria","volume":"58","author":"Svensson","year":"2002","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.pt.2020.02.005_bb0175","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.1128\/AAC.00252-10","article-title":"Population pharmacokinetics and pharmacodynamics of artemether and lumefantrine during combination treatment in children with uncomplicated falciparum malaria in Tanzania","volume":"54","author":"Hietala","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pt.2020.02.005_bb0180","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1365-2125.2005.02508.x","article-title":"Semi-mechanistic pharmacokinetic\/pharmacodynamic modelling of the antimalarial effect of artemisinin","volume":"60","author":"Gordi","year":"2005","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.pt.2020.02.005_bb0185","doi-asserted-by":"crossref","first-page":"5484","DOI":"10.1128\/AAC.00044-12","article-title":"Pharmacokinetics and pharmacodynamics of oral artesunate monotherapy in patients with uncomplicated Plasmodium falciparum malaria in western Cambodia","volume":"56","author":"Saunders","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pt.2020.02.005_bb0190","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1208\/s12248-017-0141-1","article-title":"Population pharmacokinetic and pharmacodynamic modeling of artemisinin resistance in Southeast Asia","volume":"19","author":"Lohy Das","year":"2017","journal-title":"AAPS J."},{"key":"10.1016\/j.pt.2020.02.005_bb0195","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12936-018-2278-5","article-title":"Population pharmacokinetic and pharmacodynamic properties of artesunate in patients with artemisinin sensitive and resistant infections in Southern Myanmar","volume":"17","author":"Lohy Das","year":"2018","journal-title":"Malar. J."},{"key":"10.1016\/j.pt.2020.02.005_bb0200","doi-asserted-by":"crossref","first-page":"6419","DOI":"10.1128\/AAC.00482-15","article-title":"Altering antimalarial drug regimens may dramatically enhance and restore drug effectiveness","volume":"59","author":"Kay","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pt.2020.02.005_bb0205","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1093\/cid\/cis958","article-title":"Effect of high-dose or split-dose artesunate on parasite clearance in artemisinin-resistant falciparum malaria","volume":"56","author":"Das","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.pt.2020.02.005_bb0210","series-title":"Guidelines for the Treatment of Malaria","author":"World Health Organization","year":"2015"},{"key":"10.1016\/j.pt.2020.02.005_bb0215","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0140-6736(82)90268-9","article-title":"Antimalarial activity of mefloquine and qinghaosu","volume":"320","author":"Jiang","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.pt.2020.02.005_bb0220","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/0035-9203(89)90322-2","article-title":"Treatment of malaria \u2013 some considerations and limitations of the current methods of assessment","volume":"83","author":"White","year":"1989","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.pt.2020.02.005_bb0225","doi-asserted-by":"crossref","first-page":"240","DOI":"10.4269\/ajtmh.1989.40.240","article-title":"Stage specific actions of antimalarial drugs on Plasmodium falciparum in culture","volume":"40","author":"Geary","year":"1989","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.pt.2020.02.005_bb0230","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1093\/infdis\/jiy673","article-title":"Artemisinin resistance and stage dependency of parasite clearance in falciparum malaria","volume":"219","author":"Intharabut","year":"2019","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.pt.2020.02.005_bb0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030949","article-title":"P. falciparum in vitro killing rates allow to discriminate between different antimalarial mode-of-action","volume":"7","author":"Sanz","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pt.2020.02.005_bb0240","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/infdis\/jiw234","article-title":"Defining the effectiveness of antimalarial chemotherapy: investigation of the lag in parasite clearance following drug administration","volume":"214","author":"Khoury","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.pt.2020.02.005_bb0245","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/1475-2875-10-339","article-title":"Standardizing the measurement of parasite clearance in falciparum malaria: the parasite clearance estimator","volume":"10","author":"Flegg","year":"2011","journal-title":"Malar. J."},{"key":"10.1016\/j.pt.2020.02.005_bb0250","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa1315860","article-title":"Spiroindolone KAE609 for falciparum and vivax malaria","volume":"371","author":"White","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pt.2020.02.005_bb0255","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1086\/340213","article-title":"Central role of the spleen in malaria parasite clearance","volume":"185","author":"Chotivanich","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.pt.2020.02.005_bb0260","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1128\/AAC.00197-15","article-title":"Artemisinin-resistant Plasmodium falciparum parasites exhibit altered patterns of development in infected erythrocytes","volume":"59","author":"Hott","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pt.2020.02.005_bb0265","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jtbi.2017.07.017","article-title":"A mechanistic model quantifies artemisinin-induced parasite growth retardation in blood-stage Plasmodium falciparum infection","volume":"430","author":"Cao","year":"2017","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.pt.2020.02.005_bb0270","doi-asserted-by":"crossref","first-page":"7701","DOI":"10.1073\/pnas.1618939114","article-title":"Host-mediated impairment of parasite maturation during blood-stage Plasmodium infection","volume":"114","author":"Khoury","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pt.2020.02.005_bb0275","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1128\/AAC.00527-07","article-title":"Multiple antibiotics exert delayed effects against the Plasmodium falciparum apicoplast","volume":"51","author":"Dahl","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pt.2020.02.005_bb0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000376","article-title":"Delayed death in the malaria parasite Plasmodium falciparum is caused by disruption of prenylation-dependent intracellular trafficking","volume":"17","author":"Kennedy","year":"2019","journal-title":"PLoS Biol."},{"key":"10.1016\/j.pt.2020.02.005_bb0285","article-title":"Estimation of the total parasite biomass in acute falciparum malaria from plasma PfHRP2","volume":"2","author":"Dondorp","year":"2005","journal-title":"PLoS Med."},{"key":"10.1016\/j.pt.2020.02.005_bb0290","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/nprot.2006.69","article-title":"Real-time in vivo imaging of transgenic bioluminescent blood stages of rodent malaria parasites in mice","volume":"1","author":"Franke-Fayard","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.pt.2020.02.005_bb0295","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12916-015-0365-9","article-title":"Microvascular obstruction and endothelial activation are independently associated with the clinical manifestations of severe falciparum malaria in adults: an observational study","volume":"13","author":"Hanson","year":"2015","journal-title":"BMC Med."},{"key":"10.1016\/j.pt.2020.02.005_bb0300","first-page":"50","article-title":"Frequency of early rising parasitemia in falciparum malaria treated with artemisinin derivatives","volume":"32","author":"Silachamroon","year":"2001","journal-title":"Southeast Asian J. Trop. Med. Public Health"},{"key":"10.1016\/j.pt.2020.02.005_bb0305","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0035-9203(92)90217-Z","article-title":"Prognostic significance of rises in parasitemia during treatment of falciparum-malaria","volume":"86","author":"Watt","year":"1992","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.pt.2020.02.005_bb0310","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.pt.2013.04.001","article-title":"Antidogmatic approaches to artemisinin resistance: reappraisal as treatment failure with artemisinin combination therapy","volume":"29","author":"Krishna","year":"2013","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.pt.2020.02.005_bb0315","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1126\/science.1260867","article-title":"Drug resistance. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates","volume":"347","author":"Straimer","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.pt.2020.02.005_bb0320","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature12876","article-title":"A molecular marker of artemisinin-resistant Plasmodium falciparum malaria","volume":"505","author":"Ariey","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.pt.2020.02.005_bb0325","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1126\/science.1260403","article-title":"Population transcriptomics of human malaria parasites reveals the mechanism of artemisinin resistance","volume":"347","author":"Mok","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.pt.2020.02.005_bb0330","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001823","article-title":"Defining the in vivo phenotype of artemisinin-resistant falciparum malaria: a modelling approach","volume":"12","author":"White","year":"2015","journal-title":"PLoS Med."},{"key":"10.1016\/j.pt.2020.02.005_bb0335","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177840","article-title":"Identifying artemisinin resistance from parasite clearance half-life data with a simple Shiny web application","volume":"12","author":"Tun","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.pt.2020.02.005_bb0340","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1128\/AAC.01868-12","article-title":"Reduced artemisinin susceptibility of Plasmodium falciparum ring stages in western Cambodia","volume":"57","author":"Witkowski","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pt.2020.02.005_bb0345","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1038\/s41467-018-06221-1","article-title":"Artemisinin kills malaria parasites by damaging proteins and inhibiting the proteasome","volume":"9","author":"Bridgford","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.pt.2020.02.005_bb0350","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1186\/s12936-018-2593-x","article-title":"Plasmodium falciparum artemisinin resistance monitoring in Sabah, Malaysia: in vivo therapeutic efficacy and kelch13 molecular marker surveillance","volume":"17","author":"Grigg","year":"2018","journal-title":"Malar. J."}],"container-title":["Trends in Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471492220300428?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471492220300428?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T19:53:08Z","timestamp":1778615588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471492220300428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":70,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S1471492220300428"],"URL":"https:\/\/doi.org\/10.1016\/j.pt.2020.02.005","relation":{},"ISSN":["1471-4922"],"issn-type":[{"value":"1471-4922","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Malaria Parasite Clearance: What Are We Really Measuring?","name":"articletitle","label":"Article Title"},{"value":"Trends in Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pt.2020.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}